Cardiometabolic & kidneyGuideline or statement
Cardiovascular-Liver-Metabolic Health: Recommendations in Screening, Diagnosis, and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease in Cardiovascular Disease via Modified Delphi Approach
- Expert consensus recommendations (modified Delphi)
- modified Delphi method
- international experts
Scope
As issued by the authors
For CV clinicians: (1) diagnosis and screening of MASLD with noninvasive serum and imaging tests; (2) screening for cardiovascular disease (CVD) in all individuals with MASLD regardless of established atherosclerotic risk factors; (3) management of MASLD for CVD prevention through lifestyle, pharmacologic and surgical strategies
Original publication
Cardiovascular-Liver-Metabolic Health: Recommendations in Screening, Diagnosis, and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease in Cardiovascular Disease via Modified Delphi Approach. Circulation. Published 26 December 2024. doi:10.1161/circulationaha.124.070535
Summarised from the published abstract; every number is checked against it